La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

C-MER Medical Holdings Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Dennis Lam

Directeur général

HK$6.0m

Rémunération totale

Pourcentage du salaire du PDG	95.7%
Durée du mandat du directeur général	no data
Propriété du PDG	0.9%
Durée moyenne d'occupation des postes de direction	pas de données
Durée moyenne du mandat des membres du conseil d'administration	5.4yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Dennis Lam a-t-elle évolué par rapport aux bénéfices de C-MER Medical Holdings?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	n/a	n/a	HK$63m
Mar 31 2024	n/a	n/a	HK$63m
Dec 31 2023	HK$6m	HK$6m	HK$62m
Sep 30 2023	n/a	n/a	HK$28m
Jun 30 2023	n/a	n/a	-HK$7m
Mar 31 2023	n/a	n/a	-HK$14m
Dec 31 2022	HK$6m	HK$6m	-HK$22m
Sep 30 2022	n/a	n/a	HK$545k
Jun 30 2022	n/a	n/a	HK$23m
Mar 31 2022	n/a	n/a	HK$22m
Dec 31 2021	HK$6m	HK$6m	HK$22m
Sep 30 2021	n/a	n/a	HK$25m
Jun 30 2021	n/a	n/a	HK$28m
Mar 31 2021	n/a	n/a	HK$11m
Dec 31 2020	HK$4m	HK$4m	-HK$6m
Sep 30 2020	n/a	n/a	-HK$10m
Jun 30 2020	n/a	n/a	-HK$13m
Mar 31 2020	n/a	n/a	HK$14m
Dec 31 2019	HK$1m	HK$1m	HK$41m
Sep 30 2019	n/a	n/a	HK$53m
Jun 30 2019	n/a	n/a	HK$64m
Mar 31 2019	n/a	n/a	HK$53m
Dec 31 2018	HK$1m	HK$1m	HK$43m
Sep 30 2018	n/a	n/a	HK$35m
Jun 30 2018	n/a	n/a	HK$27m
Mar 31 2018	n/a	n/a	HK$31m
Dec 31 2017	HK$4m	HK$3m	HK$40m

Rémunération vs marché: La rémunération totale de Dennis ($USD 772.44K ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 408.00K ).

Rémunération et revenus: La rémunération de Dennis a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Dennis Lam (64 yo)

no data

Titularisation

HK$6,018,000

Compensation

Dr. Shun Chiu Lam, JP, also known as Dennis, serves as Chairman and Chief Executive Officer of C-MER Medical Holdings Limited (formerly known as C-MER Eye Care Holdings Limited). Dr. Lam is also a director...

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Shun Chiu Lam	Chairman & CEO	no data	HK$6.02m	0.94% HK$ 27.6m
Xiaoting Li	Executive Director	7.3yrs	HK$3.81m	pas de données
Yau Wing Lee	Head of Hong Kong Operation & Executive Director	7.3yrs	HK$240.00k	1.07% HK$ 31.4m
Chiu Cheung Ma	Independent Non-Executive Director	6.8yrs	HK$240.00k	pas de données
Pak-kuen Auyeung	Independent Vice Chairman of the Board	3.9yrs	HK$759.00k	0.024% HK$ 714.0k
Ke Yin	Independent Non-Executive Director	1.3yrs	HK$120.00k	pas de données
Shu Kwan Ip	Independent Non-Executive Director	3.9yrs	HK$240.00k	pas de données

5.4yrs

Durée moyenne de l'emploi

64yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 3309 sont considérés comme expérimentés (ancienneté moyenne 5.2 ans).

C-MER Medical Holdings Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

Chairman & CEO recently bought HK$776k worth of stock

Chairman & CEO recently bought HK$841k worth of stock

C-MER Eye Care Holdings Limited, Annual General Meeting, May 28, 2024

C-MER Eye Care Holdings Limited Announces Board Changes, Effective July 3, 2023

Insufficient new directors

Insufficient new directors

Recent updates

Investor sentiment improves as stock rises 32%

Chairman & CEO recently bought HK$776k worth of stock

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: HK$0.025 (vs HK$0.024 in 1H 2023)

C-MER Medical Holdings Limited to Report First Half, 2024 Results on Aug 29, 2024

Chairman & CEO recently bought HK$841k worth of stock

C-MER Eye Care Holdings Limited, Annual General Meeting, May 28, 2024

New major risk - Revenue and earnings growth

C-MER Eye Care Holdings Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

First half 2023 earnings released: EPS: HK$0.024 (vs HK$0.012 in 1H 2022)

C-MER Eye Care Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

C-MER Eye Care Holdings Limited to Report First Half, 2023 Results on Aug 30, 2023

C-MER Eye Care Holdings Limited Announces Board Changes, Effective July 3, 2023

Insufficient new directors

Now 22% undervalued after recent price drop

Full year 2022 earnings released: HK$0.018 loss per share (vs HK$0.019 profit in FY 2021)

Now 22% undervalued

Insufficient new directors

Chairman & CEO recently bought HK$1.9m worth of stock

Chairman & CEO recently bought HK$1.3m worth of stock

Insufficient new directors

First half 2022 earnings released: EPS: HK$0.012 (vs HK$0.012 in 1H 2021)

Insufficient new directors

C-MER Eye Care Holdings Limited to Report First Half, 2022 Results on Aug 30, 2022

Full year 2021 earnings released: EPS: HK$0.019 (vs HK$0.006 loss in FY 2020)

C-MER Eye Care Holdings Limited, Annual General Meeting, May 24, 2022

C-MER Eye Care Holdings Limited Recommends No Payment of Any Final Dividend for the Year Ended 31 December 2021

C-MER Eye Care Holdings Limited (SEHK:3309) entered into the Sale and Purchase agreements to acquire Champion Eye Centre Limited from Yeung, Hung, Pauline Chan, Ko, DN Chan,Yip, and the Estate of Cheung for HKD 56.02 million.

C-MER Eye Care Holdings Limited (SEHK:3309) entered into an Equity Transfer Agreement to acquire 7% stake in Shenzhen Aikangjian Group Co., Ltd. from Shenzhen Capital Group Co., Ltd. for CNY 45.5 million

First half 2021 earnings released: EPS HK$0.012 (vs HK$0.02 loss in 1H 2020)

C-MER Eye Care Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021

Independent Non-Executive Director recently bought HK$1.6m worth of stock

C-MER Eye Care Holdings Limited Approves Final Dividend for the Year Ended 31 December 2020

Upcoming dividend of HK$0.02 per share

Full year 2020 earnings released: HK$0.006 loss per share (vs HK$0.04 profit in FY 2019)

Full year 2020 earnings released: HK$0.006 loss per share (vs HK$0.04 profit in FY 2019)

C-MER Eye Care Holdings Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day high: HK$6.89

C-MER Eye Care Holdings Limited (SEHK:3309) signed a Purchase Agreement to acquire 60% stake in CAD/CAM Restorative Dental Centre Limited from YIU Bun Ka for HK$12.9 million.

New 90-day high: HK$6.44

Independent Non-Executive Director recently bought HK$1.8m worth of stock

C-MER Eye Care Holdings Limited Announces Board Changes

New 90-day low: HK$5.58

Independent Non-Executive Director recently bought HK$208k worth of stock

New 90-day low: HK$5.86

First half earnings released

Independent Non-Executive Director recently bought HK$138k worth of stock

Independent Non-Executive Director recently bought HK$130k worth of stock

First half earnings released

C-MER Eye Care Holdings Limited to Report First Half, 2020 Results on Aug 28, 2020

Analyse de la rémunération des PDG

PDG

Titularisation

Compensation

Membres du conseil d'administration

Durée moyenne de l'emploi

Âge moyen